Curio Wealth’s Editas Medicine EDIT Stock Holding History

Curio Wealth’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-77	Closed	-$170	–	1258
2025 Q4	$170	Buy	+77	New	+$222	﹤0.01%	432
2025 Q3	–	Sell	-77	Closed	-$169	–	308
2025 Q2	$169	Buy	77 +76	+7,600%	+$124	﹤0.01%	335
2025 Q1	$98	Buy	+1	New	+$1	﹤0.01%	375

Other funds holding EDIT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Curio Wealth's EDIT Position: Q1 2026 in Review

Curio Wealth sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 77 shares — an estimated $170 sold.

Curio Wealth first reported a position in EDIT in Q1 2025 and held it in 3 quarters. The position peaked at $170 in Q4 2025. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Curio Wealth reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
Curio Wealth sold 77 Editas Medicine shares in Q1 2026, an estimated $170.
Curio Wealth first reported a position in Editas Medicine in Q1 2025 and held it in 3 quarters.
Curio Wealth's Editas Medicine position peaked at $170 in Q4 2025.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Curio Wealth's 13F filing for Q1 2026, filed 12 May 2026.